Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature
Karmela K Chan(Hospital for Special Surgery), Anne R. Bass(Hospital for Special Surgery), Michael A. Postow(Memorial Sloan Kettering Cancer Center), Anthony Rossi(Memorial Sloan Kettering Cancer Center), Arlyn Apollo(Memorial Sloan Kettering Cancer Center), Alexander N. Shoushtari(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), David Fernández(Hospital for Special Surgery), Cynthia M. Magro(Cornell University), Cecilia Lezcano(Memorial Sloan Kettering Cancer Center), Mario E. Lacouture(Garden City Community College), Veronica Rotemberg(Memorial Sloan Kettering Cancer Center), John A. Carrino(Hospital for Special Surgery)
Cited by 69
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
|Translational research|2020|2.3k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k